Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.9.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.6.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.6.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.6.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.6.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.34ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.34ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.34NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CH.1.1.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CH.1.1.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.9.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.9.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.9.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.9.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.4.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.4.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16669.7China
BN.1.4.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.4.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.58ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.58ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.58ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.58NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XAY.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XAY.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAY.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAY.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.71ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.71ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.71ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.71NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBC.1.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBC.1.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBC.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CP.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CP.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CP.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15159.2France
BA.5.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DN.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DN.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DN.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DN.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CL.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used